Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats

We hypothesized that the cannabinoid (CB) system may mediate the brain orexin- or ghrelin-induced visceral antinociception. Intraperitoneal injection of either CB1/2 agonist, WIN 55212 or O-Arachidonoyl ethanolamine increased the threshold volume of colonic distension-induced abdominal withdrawal re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Toshikatsu Okumura (Autore), Tsukasa Nozu (Autore), Shima Kumei (Autore), Masumi Ohhira (Autore)
Natura: Libro
Pubblicazione: Elsevier, 2018-06-01T00:00:00Z.
Soggetti:
Accesso online:Connect to this object online.
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1e7ea592b87b41cc90e233a1d9d2e9fd
042 |a dc 
100 1 0 |a Toshikatsu Okumura  |e author 
700 1 0 |a Tsukasa Nozu  |e author 
700 1 0 |a Shima Kumei  |e author 
700 1 0 |a Masumi Ohhira  |e author 
245 0 0 |a Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats 
260 |b Elsevier,   |c 2018-06-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2018.06.001 
520 |a We hypothesized that the cannabinoid (CB) system may mediate the brain orexin- or ghrelin-induced visceral antinociception. Intraperitoneal injection of either CB1/2 agonist, WIN 55212 or O-Arachidonoyl ethanolamine increased the threshold volume of colonic distension-induced abdominal withdrawal reflex in rats, suggesting CB could induce visceral antinociception. Pretreatment with either the CB1 or CB2 antagonist potently blocked the centrally injected orexin-A-induced antinociceptive action against colonic distension while CB2 but not CB1 antagonist blocked the brain ghrelin-induced visceral antinociception. These results suggest that the cannabinoid signaling may be involved in the central orexin- or ghrelin-induced antinociceptive action in a different mechanistic manner. Keywords: Cannabinoid, Neuropeptide, Visceral sensation 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 137, Iss 2, Pp 230-232 (2018) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861318301002 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/1e7ea592b87b41cc90e233a1d9d2e9fd  |z Connect to this object online.